Correlation Between Heart Test and Neuropace
Can any of the company-specific risk be diversified away by investing in both Heart Test and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Heart Test and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Heart Test Laboratories and Neuropace, you can compare the effects of market volatilities on Heart Test and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Heart Test with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Heart Test and Neuropace.
Diversification Opportunities for Heart Test and Neuropace
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Heart and Neuropace is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Heart Test Laboratories and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Heart Test is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Heart Test Laboratories are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Heart Test i.e., Heart Test and Neuropace go up and down completely randomly.
Pair Corralation between Heart Test and Neuropace
Given the investment horizon of 90 days Heart Test Laboratories is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, Heart Test Laboratories is 2.0 times less risky than Neuropace. The stock trades about -0.06 of its potential returns per unit of risk. The Neuropace is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest 638.00 in Neuropace on August 29, 2024 and sell it today you would earn a total of 387.00 from holding Neuropace or generate 60.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Heart Test Laboratories vs. Neuropace
Performance |
| Timeline |
| Heart Test Laboratories |
| Neuropace |
Heart Test and Neuropace Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Heart Test and Neuropace
The main advantage of trading using opposite Heart Test and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Heart Test position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.| Heart Test vs. Tivic Health Systems | Heart Test vs. Bluejay Diagnostics | Heart Test vs. Nuwellis | Heart Test vs. NeuroMetrix |
| Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |